Tranexamic acid for percutaneous nephrolithotomy

Brent Cleveland, Brett Norling, Hill Wang, Vardhil Gandhi, Carrie L. Price, Michael Borofsky, Vernon Pais, Philipp Dahm

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of TXA in adults with kidney stones undergoing PCNL.

Original languageEnglish (US)
Article numberCD015122
JournalCochrane Database of Systematic Reviews
Volume2022
Issue number3
DOIs
StatePublished - Mar 14 2022

Bibliographical note

Funding Information:
We thank Cochrane Urology, Cochrane Cancer Network, and our contact editor Mi Ah Han for their support. We thank Andrea Takeda for copy editing the protocol. We would also like to thank the peer referees, Drs Seth Bechis, Amita Sharma, Christian Türk, and Konrad Wilhelm for their valuable input and constructive criticism.

Publisher Copyright:
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Fingerprint

Dive into the research topics of 'Tranexamic acid for percutaneous nephrolithotomy'. Together they form a unique fingerprint.

Cite this